No Data
No Data
Qingdao Haier Biomedical Co.,Ltd's (SHSE:688139) Shares Not Telling The Full Story
Qingdao Haier Biomedical Co., Ltd. (688139.SH): Cumulative repurchase of 0.44% of the company's shares.
Qingdao Haier Biomedical Co., Ltd. (688139.SH) announced on September 2nd that as of August 31, 2024, the company has repurchased a total of 1,387,844 shares of the company through the centralized bidding trading method on the Shanghai Stock Exchange, accounting for 0.44% of the total share capital of 317,952,508 shares. The highest price of the repurchase transaction was 32.31 yuan/share, the lowest price was 24.64 yuan/share, and the total amount of funds paid was 40,435,425.54 yuan (excluding transaction costs).
Qingdao Haier Biomedical Co., Ltd. 2024 Semi-annual Report Full Text
Summary of Half-Year Report of qingdao haier biomedical co., ltd. in 2024
Qingdao Haier Biomedical Co., Ltd. (688139.SH): The net income for the first half of the year was 0.234 billion yuan, a year-on-year decrease of 15.84%.
On August 22, qingdao haier biomedical co., ltd. (688139.SH) released its semi-annual report, with revenue of 1.223 billion yuan, a year-on-year decrease of 3.71%, net income of 0.234 billion yuan, a year-on-year decrease of 15.84%, non-GAAP net income of 0.21 billion yuan, a year-on-year decrease of 7.52%, and basic earnings per share of 0.74 yuan.
Will Weakness in Qingdao Haier Biomedical Co.,Ltd's (SHSE:688139) Stock Prove Temporary Given Strong Fundamentals?
No Data
No Data